Fitch: Express Scripts could lose $20 billion after Anthem contract expires

Fitch Ratings is projecting pharmacy benefits manager Express Scripts (NASDAQ: ESRX) could lose about $20 billion in revenue after the expiration of its contract with Anthem at the end of 2019. Last year, after an ongoing legal battle, Anthem said it would drop Express Scripts. “If customer retention ultimately requires increased pricing concessions, it could further eat into ESRX's margins over the longer term as contracts roll,” Fitch said in a release. “While Anthem's dispute w ith ESRX…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news